Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 11
Submit an article Journal homepage
2,070
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Giulia Mesianoa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Giovanni Grignania Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Erika Fiorinob Department of Oncology, University of Torino, Candiolo(Torino) Italy
,
Valeria Leucia Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;b Department of Oncology, University of Torino, Candiolo(Torino) Italy
,
Ramona Rotolob Department of Oncology, University of Torino, Candiolo(Torino) Italy
,
Lorenzo D’Ambrosioa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;b Department of Oncology, University of Torino, Candiolo(Torino) ItalyORCID Iconhttps://orcid.org/0000-0003-3294-8819
ORCID Icon,
Chiara Salfib Department of Oncology, University of Torino, Candiolo(Torino) Italy
,
Loretta Gammaitonia Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Lidia Giraudoa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Alberto Pisacanec Pathology Division, Candiolo Cancer Institute, FPO-IRCCS, Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Sara Buterad Department of Molecular Biotechnologies and Healthy Sciences, Haematology Division 1, University of Torino, Italy
,
Ymera Pignochinoa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;b Department of Oncology, University of Torino, Candiolo(Torino) Italy
,
Marco Basiricóa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Federica Capozzia Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy
,
Anna Sapinoc Pathology Division, Candiolo Cancer Institute, FPO-IRCCS, Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;e Department of Medical Sciences, University of Torino, Italy
,
Massimo Agliettaa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;b Department of Oncology, University of Torino, Candiolo(Torino) Italy
&
Dario Sangioloa Medical Oncology Division, Candiolo Cancer Institute, FPO–IRCCS. Str. Prov. 142, km 3.95, I-10060, Candiolo (To), Italy;b Department of Oncology, University of Torino, Candiolo(Torino) ItalyCorrespondence[email protected]
 show all
Article: e1465161 | Received 19 Sep 2017, Accepted 10 Apr 2018, Published online: 06 Aug 2018

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.